PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7532384-5	1995	Concurrent treatment with TNF alpha and the antioxidant, Trolox, or the iron-chelating agent, desferrioxamine, also reduces NOS activity.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	57-63	tumor necrosis factor	Rattus norvegicus	26-35	
19181934-9	2009	Trolox also mitigated TNF-alpha induced changes.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	0-6	tumor necrosis factor	Rattus norvegicus	22-31	
17906102-9	2007	The antioxidant Trolox modulated TNF-alpha-induced changes in Bax/Bcl-xl, cell injury, and MAPKs.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	16-22	tumor necrosis factor	Rattus norvegicus	33-42	
7532384-7	1995	Trolox and BCNU, combined, blocked TNF alpha stimulation of NOS greater than either agent alone.	6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid	0-6	tumor necrosis factor	Rattus norvegicus	35-44